News
Investor's Business Daily on MSN58m
Gilead Topples On A Surprise Setback For Its 99.9% Effective HIV Drug
Gilead stock toppled Thursday on a report CVS won't add the company's new HIV prevention drug, Yeztugo, to its commercial ...
(Reuters) -Gilead Sciences' unit Kite Pharma said on Thursday it will acquire privately-held biotech firm Interius ...
The Hartford Healthcare Fund (I Share) outperformed the S&P Composite 1500 Health Care Index during the quarter. Read more ...
DUBAI, UAE, Aug. 21, 2025 /PRNewswire/ -- The MarTech Summit is expanding once again— our next stop: Dubai. We're excited to bring our globally recognised summit series to the UAE. The MarTech Summit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback